Skip to main content

External Ophthalmoplegia, Progressive, with mtDNA Deletions, AR 3

OMIM ID:

autosomal recessive

External Ophthalmoplegia, Progressive, with mtDNA Deletions, AR 3

Alternate Names

PEOB3
Progressive External Ophthalmoplegia Autosomal Recessive 3

Defective Genes

TK2

Clinical Characteristics

Ocular Features

The ophthalmoplegia is adult in onset (approx. age 40 years) and progressive.  Severe blepharoptosis is an associated sign.

Systemic Features

Proximal muscle weakness and atrophy in the shoulder girdle and legs were features in the two reported patients.  Rising from a squatting position and walking up stairs may be particularly difficult.  Dysarthria and dysphagia are associated findings.

Muscle biopsy showed mitochondrial myopathy.  Multiple mtDNA deletions occur in skeletal muscles.  

Genetics

Inheritance

One family with two sisters has been reported with this condition.  Both had compound heterozygous mutations in the thymidine kinase gene (TK2) (16q21) and multiple deletions in mitochondrial DNA.

A similar condition, External Ophthalmoplegia, Progressive, with mtDNA Deletions, AR 4, (617070) is caused by mutations in the DGUOK gene. 

Pedigree

Autosomal recessive

In order for autosomal recessive disorders to be expressed, offspring generally must inherit two mutations, one from each carrier parent.  Carriers with only one mutation, such as the parents, do not have clinical disease.  Note that carrier parents can expect that 1 in 4 children (25%) will inherit both mutations and have the disorder, 2 in 4 children (50%) will be carriers like their parents, while 1 in 4 children (25%) inherit neither mutation.

Image
Sample pedigree of autosomal recessive inheritance

In order for autosomal recessive disorders to be expressed, offspring generally must inherit two mutations, one from each carrier parent. Carriers with only one mutation, such as the parents, do not have clinical disease. Note that carrier parents can expect that 1 in 4 children (25%) will inherit both mutations and have the disorder, 2 in 4 children (50%) will be carriers like their parents, while 1 in 4 children (25%) inherit neither mutation.

Treatment & Management

There is no treatment for the generalized condition but blepharoplasty may be required.

Selected Resources

Publications

Displaying 1 - 1 of 1

Thymidine kinase 2 mutations in autosomal recessive progressive external ophthalmoplegia with multiple mitochondrial DNA deletions

PubMedID: 21937588